Abstract
The therapeutic approach to schizophrenia has progressed considerably during the past years. The introduction of phenothiazines, butyrophenones and newer antipsychotic drugs has resulted in shorter hospitalizations and fewer relapses. There are now several dozens different antipsychotic drugs in clinical use. These belong to only a few families and, in fact, a chemical similarity exists between all of them (1). If this similarity is related to the mechanism of action of these drugs, then all should have the same clinical indications. On the whole, controlled trials aimed at finding “the right drug for the right patient” have not been very successful (2).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Janssen, P.A. In: Neuropsychopharmacology (eds. Bente, D. and Bradley, P.B.) 4:151, Elsevier, Amsterdam, 1965.
Gardos, G.J.: Nerv. Ment. Dis. 159: 343, 1974.
Merlis, S., Sheppard, C, Collins, L. et al.: Amer. J. Psychiat. 126: 1647, 1970.
Hollister, L.: Clinical Use of Psychotherapeutic Drugs. Charles C. Thomas, Springfield, pp. 192, 1973.
Ahlenius, S. and Engel, J.: Eur. J. Pharmacol. 15: 187, 1971.
Sargant, W.: Lancet 2: 634, 1963.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Korczyn, A.D. (1977). Combined Use of Neuroleptic Drugs. In: Gershon, E.S., Belmaker, R.H., Kety, S.S., Rosenbaum, M. (eds) The Impact of Biology on Modern Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0778-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0778-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0780-8
Online ISBN: 978-1-4684-0778-5
eBook Packages: Springer Book Archive